Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/2/26 16:05 | 6/30/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Simon Amy | MA | O | Chief Me | 4 | S.m | -749 | 19.27 | 0 | -39 | 103 | D | |||||||||||||||
7/1/26 16:05 | 6/29/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Evans John M. | MA | DO | CEO | 6 | S.dm | -6,847 | 26.26 | 0 | -261 | 1,180 | D | |||||||||||||||
6/29/26 14:17 | 6/25/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Fmr LLC | MA | TH | See Rema | 3 | S.m | -11,043 | 33.09 | 0 | -334 | 3,214 | I | |||||||||||||||
4/6/26 17:39 | 4/1/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Cavanagh Bethany J | MA | O | SVP,Fina | 5 | S | -455 | 28.50 | 0 | -16 | 51 | D | |||||||||||||||
4/6/26 17:39 | 4/1/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Bellon Christine | MA | O | GC | 6 | S | -985 | 29.62 | 0 | -33 | 117 | D | |||||||||||||||
4/6/26 17:34 | 4/1/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Ciaramella Giuseppe | MA | O | P | 3 | S.d | -1,547 | 28.51 | 0 | -54 | 218 | D | |||||||||||||||
1/5/26 16:16 | 12/31/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Emany Sravan Kumar | MA | O | CFO | 1 | S | -171 | 27.10 | 0 | -6 | 74 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |